Long-term outcome of patients on continuous-flow left ventricular assist device support Koji Takeda, MD, PhD, Hiroo Takayama, MD, PhD, Bindu Kalesan, PhD, MPH, Nir Uriel, MD, Paolo C. Colombo, MD, Ulrich P. Jorde, MD, Yoshifumi Naka, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 148, Issue 4, Pages 1606-1614 (October 2014) DOI: 10.1016/j.jtcvs.2014.04.009 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 A, On-device survival of the entire cohort. B, Freedom from rehospitalization rate for any reason. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 1606-1614DOI: (10.1016/j.jtcvs.2014.04.009) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions
Figure 2 Serial change of left ventricular diastolic dimension during CF-LVAD support. LVEDD, Left ventricular end-diastolic diameter. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 1606-1614DOI: (10.1016/j.jtcvs.2014.04.009) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions
Figure 3 Time course of significant (A) AI and (B) TR rate during CF-LVAD support. AI, Aortic insufficiency; TR, tricuspid regurgitation. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 1606-1614DOI: (10.1016/j.jtcvs.2014.04.009) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions